Drugs / Low dose of quadrivalent VLP vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02233816 | Jul 2014 → Jun 2015 | respiratory tract infectious disorder, viral infectious disease | Medicago | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Low dose of quadrivalent VLP vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02233816 ↗ |
| Modality | Vaccine | “plant-derived virus-like-particle (VLP) vaccine candidate” PMID 31166987 ↗ Jun 2019 |
| Route | Intramuscular | “a single intramuscular injection of plant-derived Seasonal VLP Quadrivalent Influenza Vaccine administered to healthy adults 18-49 years of age” NCT02233816 ↗ |